Scarica l'app Stockscreener
1.51
7.93%
-0.13
Dopo l'orario di chiusura:
1.51
Mindwalk Holdings Corp Borsa (HYFT) Ultime notizie
MindWalk Holdings Added to Russell 3000E Index, Boosting Bio-Native AI Visibility - TipRanks
Russell 3000E addition expands MindWalk (NASDAQ: HYFT) index access - Stock Titan
MindWalk added to Russell 3000E Index effective June 26 - Investing.com
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models - The Globe and Mail
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity - Business Wire
Top MindWalk (HYFT) Competitors 2026 - MarketBeat
H.C. Wainwright reiterates Buy on MindWalk stock, $5 target By Investing.com - Investing.com South Africa
MindWalk Holdings Corp. Financial Disclosures & Filings - TradingView
MindWalk Holdings Corp. (HYFT) Files Patent for Advanced AI in L - GuruFocus
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data - Investing News Network
MindWalk Files European Patent for High-Dimensional Biological Data Layer Powering AI Drug Discovery - TipRanks
MindWalk (NASDAQ: HYFT) seeks EU patent on AI-driven biological data layer - Stock Titan
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery - Yahoo Finance
MindWalk Holdings Corp.(NasdaqCM:HYFT) added to Russell Microcap Value Benchmark Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell 3000E Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell Microcap Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell 3000E Growth Benchmark - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM:HYFT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
MindWalk Holdings Corp.(NasdaqCM: HYFT) added to Russell 3000E Value Benchmark - marketscreener.com
MindWalk Holdings Corp. Actuals & Estimates (NASDAQ:HYFT) - TradingView
HYFT Forecast — Price Target — Prediction for 2027 - TradingView
TQB0 Forecast — Price Target — Prediction for 2027 - TradingView
MindWalk (HYFT) Earnings Date and Reports 2026 - MarketBeat
Price to earnings forward of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
Price to sales forward of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
Price to book forward of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
This Stock Is A Once-In-A-Lifetime Steal Radio-canada (R6akZrRcrT) - Mshale
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - marketscreener.com
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - Benzinga
HYFT News | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
HYFT Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Investment PhaseLow Growth Earnings - newsline.com
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ - marketscreener.com
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - 01net
MindWalk CEO to Join Jones AI Day Panel on Future of AI Drug Discovery - TipRanks
MindWalk (NASDAQ: HYFT) CEO joins Jones AI Day panel on AI drug discovery - Stock Titan
MINDWALK HOLDINGS CORP (HYFT) Stock Chart - ChartMill
HYFT Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 3.01%Positive Surprise Momentum - newsline.com
HYFT Unveils ReefIQ for Enhanced AI Drug Discovery - GuruFocus
MindWalk Holdings Corp. Launches ReefIQ™ for AI-Driven Drug Disc - GuruFocus
MindWalk Holdings Unveils ReefIQ Context Layer to Power AI Drug Discovery - TipRanks
MindWalk (NASDAQ: HYFT) debuts ReefIQ context layer for AI drug discovery - Stock Titan
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery - The Joplin Globe
HYFT Q1 2026 Earnings: EPS Falls Short of Estimates as Stock Gains 3.75%EPS Growth Report - newsline.com
HYFT Q1 2026 Earnings: EPS Misses Estimates, Stock Slides Over 9%Earnings Power Value - newsline.com
MindWalk Showcases HYFT® Platform With Pan-Serotype Dengue Preclinical Data - TipRanks
MindWalk (NASDAQ: HYFT) reports HYFT AI preclinical dengue antibodies across all four serotypes - Stock Titan
MindWalk's HYFT Platform Shows Promising Preclinical Dengue Vacc - GuruFocus
MindWalk reports preclinical dengue vaccine data By Investing.com - Investing.com Nigeria
Bio-Native AI therapeutics MindWalk sets March 12 Q3 earnings call - Stock Titan
MindWalk reports preclinical dengue vaccine data - Investing.com
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Camp - Business Wire
HYFT Q1 2026 Earnings: EPS Misses Estimates by 42.6%, Stock DeclinesOne-Time Gain Impact - thelegaladvocate.com
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):